BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27699893)

  • 1. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
    Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein.
    Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13260-5. PubMed ID: 19651603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
    Dyson HJ; Wright PE
    J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
    Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
    J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.
    Lipinski KS; Fax P; Wilker B; Hennemann H; Brockmann D; Esche H
    Virology; 1999 Mar; 255(1):94-105. PubMed ID: 10049825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral E1A Exploits Flexibility and Disorder to Target Cellular Proteins.
    Murrali MG; Felli IC; Pierattelli R
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33187345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.
    Dorsman JC; Teunisse AF; Zantema A; van der Eb AJ
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():423-6. PubMed ID: 9018065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
    Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
    J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of allostery by protein intrinsic disorder.
    Ferreon AC; Ferreon JC; Wright PE; Deniz AA
    Nature; 2013 Jun; 498(7454):390-4. PubMed ID: 23783631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
    Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
    Sang N; Avantaggiati ML; Giordano A
    J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional control by adenovirus E1A conserved region 3 via p300/CBP.
    Pelka P; Ablack JN; Torchia J; Turnell AS; Grand RJ; Mymryk JS
    Nucleic Acids Res; 2009 Mar; 37(4):1095-106. PubMed ID: 19129215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.
    O'Connor MJ; Zimmermann H; Nielsen S; Bernard HU; Kouzarides T
    J Virol; 1999 May; 73(5):3574-81. PubMed ID: 10196247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
    Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus E1A Activation Domain Regulates H3 Acetylation Affecting Varied Steps in Transcription at Different Viral Promoters.
    Hsu E; Pennella MA; Zemke NR; Eng C; Berk AJ
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and modulation of p53 by p300/CBP coactivators.
    Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
    Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP.
    Lundblad JR; Kwok RP; Laurance ME; Harter ML; Goodman RH
    Nature; 1995 Mar; 374(6517):85-8. PubMed ID: 7870179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.
    Lee CW; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2010 Nov; 49(46):9964-71. PubMed ID: 20961098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
    Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
    Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.